Detalhe da pesquisa
1.
Amivantamab plus Chemotherapy in NSCLC with EGFR Exon 20 Insertions.
N Engl J Med
; 389(22): 2039-2051, 2023 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37870976
2.
Disruptive and Truncating TP53 Mutations Are Associated with African-Ancestry and Worse Prognosis in Brazilian Patients with Lung Adenocarcinoma.
Pathobiology
; 90(5): 344-355, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37031678
3.
Detection of NTRK fusions by RNA-based nCounter is a feasible diagnostic methodology in a real-world scenario for non-small cell lung cancer assessment.
Sci Rep
; 13(1): 21168, 2023 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38036758